<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee JY</submitter><funding>Patient-Doctor Shared Decision Marking Research Center</funding><funding>2024 Clinical Practice Guideline Research Fund</funding><pagination>1060-1082</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11625847</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>85(6)</volume><pubmed_abstract>Active surveillance (AS) has been widely adopted as an alternative to immediate surgery owing to the indolent nature and favorable outcomes of papillary thyroid microcarcinoma (PTMC). AS is generally recommended for tumors measuring ≤1 cm without aggressive cytological subtypes, risk of gross extrathyroidal extension (ETE), lymph node metastasis (LNM), or distant metastasis. AS requires careful patient selection based on various patient and tumor characteristics, and ultrasound (US) findings. Moreover, during AS, regular US is performed to monitor any signs of tumor progression, including tumor growth, new US features of potential gross ETE, and LNM. Therefore, appropriate imaging-based assessment plays a crucial role in determining whether AS or surgery should be pursued. However, detaile</pubmed_abstract><journal>Journal of the Korean Society of Radiology</journal><pubmed_title>Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.</pubmed_title><pmcid>PMC11625847</pmcid><funding_grant_id>RS-2023-KH142322</funding_grant_id><pubmed_authors>Jung SL</pubmed_authors><pubmed_authors>Korean Society of Thyroid Radiology (KSThR)</pubmed_authors><pubmed_authors>Lee CY</pubmed_authors><pubmed_authors>Na DG</pubmed_authors><pubmed_authors>Yoon JH</pubmed_authors><pubmed_authors>Lee JY</pubmed_authors><pubmed_authors>Chung SR</pubmed_authors><pubmed_authors>Korean Society of Radiology</pubmed_authors><pubmed_authors>Shin JH</pubmed_authors><pubmed_authors>Hahn SY</pubmed_authors><pubmed_authors>Baek JH</pubmed_authors><pubmed_authors>Lim HK</pubmed_authors><pubmed_authors>Kim JH</pubmed_authors><pubmed_authors>Lee MK</pubmed_authors><pubmed_authors>Sung JY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.</name><description>Active surveillance (AS) has been widely adopted as an alternative to immediate surgery owing to the indolent nature and favorable outcomes of papillary thyroid microcarcinoma (PTMC). AS is generally recommended for tumors measuring ≤1 cm without aggressive cytological subtypes, risk of gross extrathyroidal extension (ETE), lymph node metastasis (LNM), or distant metastasis. AS requires careful patient selection based on various patient and tumor characteristics, and ultrasound (US) findings. Moreover, during AS, regular US is performed to monitor any signs of tumor progression, including tumor growth, new US features of potential gross ETE, and LNM. Therefore, appropriate imaging-based assessment plays a crucial role in determining whether AS or surgery should be pursued. However, detaile</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-22T16:52:55.81Z</modification><creation>2025-04-06T01:57:44.289Z</creation></dates><accession>S-EPMC11625847</accession><cross_references><pubmed>39660311</pubmed><doi>10.3348/jksr.2024.0132</doi></cross_references></HashMap>